Solventum Corp (SOLV) stock
SOLVNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3092% above fair value
$88.81+0.19 (+0.21%)
Close on Nov 12, 2026Market cap $15.12BP/E 99.8Yield –
Solventum gross margin
Gross margin is gross profit as a percentage of revenue.
Solventum's gross margin for the twelve months ending Sep 30, 2026 was 54.8%. For fiscal 2025 it was 53.5%, against 55.6% the year before.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 53.5% | −2.2 |
| FY2024 | Dec 31, 2024 | 55.6% | −1.6 |
| FY2023 | Dec 31, 2023 | 57.3% | −0.5 |
| FY2022 | Dec 31, 2022 | 57.7% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 54.5% | +0.3 |
| Q2 FY2026 | Jun 30, 2026 | 58.2% | +3.8 |
| Q1 FY2026 | Mar 31, 2026 | 54.7% | +0.8 |
| Q4 FY2025 | Dec 31, 2025 | 51.4% | −2.5 |
| Q3 FY2025 | Sep 30, 2025 | 54.2% | −1.8 |
| Q2 FY2025 | Jun 30, 2025 | 54.4% | −0.3 |
| Q1 FY2025 | Mar 31, 2025 | 53.8% | −4.3 |
| Q4 FY2024 | Dec 31, 2024 | 53.9% | −2.9 |
| Q3 FY2024 | Sep 30, 2024 | 56.0% | −2.3 |
| Q2 FY2024 | Jun 30, 2024 | 54.6% | −2.6 |
| Q1 FY2024 | Mar 31, 2024 | 58.1% | +1.6 |
| Q4 FY2023 | Dec 31, 2023 | 56.9% | – |
| Q3 FY2023 | Sep 30, 2023 | 58.3% | – |
| Q2 FY2023 | Jun 30, 2023 | 57.3% | – |
| Q1 FY2023 | Mar 31, 2023 | 56.5% | – |
See a number that looks wrong?